BRAEBURN INC.

BRIXADI

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

BRAEBURN INC.

Brixadi HCPCS:

J0576

HCPCS Code Descriptor:

Injection, buprenorphine extended-release (brixadi), 1 mg

Category:

J Code

Brixadi NDCs:

No actively aligned NDCs found

Primary Type:

Opioid Analgesic

Generic/Specialty Status:

Single-Source

Package Type:

Syringe

Route of Administration:

Subcutaneous

Brixadi CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Brixadi:

BRIXADI is a Opioid Analgesic drug manufactured by BRAEBURN INC. and administered via the Subcutaneous route of administration. The J Code: J0576 is aligned to the drug BRIXADI.

ACCESS PRICING AND MORE BY REGISTERING

J0576 Added Date:

January 1, 2024

J0576 Effective Date:

January 1, 2024

J0576 Termination Date:

April 1, 2024

We have not yet identified a manufacturer source of Brixadi billing and coding information.
Brixadi patient assistance information can be found through Braeburn Pharmaceuticals at the URL: https://www.brixadi.com/
BRIXADI prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for BRIXADI. Please check back in a few weeks.